TUBB4A

TUBB4A encodes a β-tubulin isotype that is a structural constituent of microtubules with critical roles in neurons and oligodendrocytes. Missense mutations in TUBB4A cause distinct neurological diseases depending on the affected residue: mutations at the intradimer interface (e.g., p.Asp249Asn) cause hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) through oligodendrocyte loss and disrupted microtubule dynamics, while the p.Arg2Gly mutation causes DYT4 dystonia with altered neuronal morphology but preserved microtubule polymerization (PMID:23582646, PMID:23595291, PMID:28973395, PMID:32463361). Hypomyelination-associated mutations act through a dominant toxic gain-of-function mechanism that drives microtubule accumulation in oligodendrocytes, impairs myelin gene expression, and causes progressive demyelination (PMID:28973395, PMID:28393430). In cancer cells, TUBB4A interacts with MYH9 to protect the nucleus during constricted migration and sustains β-catenin signaling by promoting GSK3β ubiquitination and degradation (PMID:35589707).

1. 1986 Medium

   Establishing that divergent β-tubulin isotypes have tissue-specific expression patterns revealed that functionally distinct tubulin genes serve different cell types, setting the stage for understanding isotype-specific roles.

   Evidence Northern blot expression analysis of chicken β-tubulin genes across tissues and cell types

   PMID:3025656

   Open questions at the time

   • Chicken ortholog expression may not fully recapitulate mammalian TUBB4A tissue distribution
   • Expression pattern does not establish functional non-redundancy
2. 2013 High

   Identification of TUBB4A as the causative gene for two distinct neurological diseases — H-ABC (p.Asp249Asn) and DYT4 dystonia (p.Arg2Gly) — established that this β-tubulin isotype is essential for normal brain development and myelination.

   Evidence Exome sequencing of H-ABC patient trios with structural modeling; genome-wide linkage and sequencing in DYT4 families with mRNA quantification

   PMID:23582646 PMID:23595291

   Open questions at the time

   • Mechanism by which individual mutations cause disease was not yet experimentally resolved
   • Whether mutations affect tubulin folding, dimerization, or polymerization was inferred from modeling only
3. 2014 Low

   3D structural modeling predicted that different H-ABC mutations impair distinct aspects of tubulin function — some disrupting motor protein/MAP binding and others affecting longitudinal intradimer contacts — suggesting mutation-specific pathogenic mechanisms.

   Evidence Computational 3D structural modeling of αβ-tubulin heterodimer with mapped TUBB4A mutations

   PMID:24850488

   Open questions at the time

   • Predictions were purely computational with no biochemical or cell-biological validation
   • Whether motor protein binding is actually impaired by specific mutations was not tested
   • No in vitro reconstitution of mutant microtubules
4. 2017 High

   Systematic comparison of multiple TUBB4A mutations demonstrated that disease mutations cause cell-type-specific and mutation-specific defects: dystonia mutations alter neuronal morphology without disrupting microtubule dynamics, while hypomyelination mutations cause toxic microtubule accumulation in oligodendrocytes via a dominant gain-of-function mechanism.

   Evidence Tubulin polymerization assays, neuronal and oligodendrocyte morphology analysis, myelin gene expression; taiep rat model with Tubb4a p.Ala302Thr confirmed by electron microscopy and human patient histology

   PMID:28393430 PMID:28973395

   Open questions at the time

   • Why microtubules specifically accumulate in oligodendrocytes rather than other cell types is unexplained
   • The downstream signaling from microtubule accumulation to oligodendrocyte death is not defined
5. 2019 Medium

   Discovery of a TUBB4A–GLUT1 interaction in glioblastoma cells raised the possibility that TUBB4A has roles beyond structural microtubule function, potentially in membrane protein trafficking or stabilization.

   Evidence Mass spectrometry on human GBM specimens, proximity ligation assay, co-immunoprecipitation, pharmacological inhibition of TUBB4 with functional readouts

   PMID:31491891

   Open questions at the time

   • Pharmacological inhibitor CR-42-24 is not fully specific to TUBB4A; genetic KO confirmation is lacking
   • Whether TUBB4A directly binds GLUT1 or the interaction is microtubule-mediated is unclear
6. 2020 High

   A knock-in mouse model of the H-ABC mutation directly demonstrated that p.Asp249Asn causes myelination deficits, loss of oligodendrocytes and their progenitors, neuronal loss, and impaired microtubule dynamics, providing in vivo validation of the pathogenic mechanism.

   Evidence Heterozygous and homozygous Tubb4a knock-in mice with behavioral, immunohistochemical, and in vitro microtubule dynamics assays

   PMID:32463361

   Open questions at the time

   • Whether oligodendrocyte loss is cell-autonomous or secondary to neuronal pathology is not fully resolved
   • Therapeutic rescue strategies have not been tested in this model
7. 2022 High

   Beyond its structural role, TUBB4A was shown to interact with MYH9 during confined cell migration to protect the nucleus from DNA damage and to regulate β-catenin signaling by promoting GSK3β ubiquitination, revealing a signaling axis relevant to cancer metastasis.

   Evidence Reciprocal co-IP, TUBB4A KO in prostate cancer cells, γH2AX/53BP1 staining, ubiquitination assays, conditional Tubb4a KO mouse tumor model

   PMID:35589707

   Open questions at the time

   • Whether the MYH9–TUBB4A interaction is direct or requires other adaptor proteins is not fully defined
   • Relevance of this cancer signaling axis to non-cancer contexts (neurons, oligodendrocytes) is unknown

• It remains unknown how TUBB4A mutations lead to selective vulnerability of oligodendrocytes versus neurons, what structural features distinguish TUBB4A from other β-tubulin isotypes functionally, and whether the MYH9/GSK3β signaling axis is active in the brain.
• No structural or biochemical explanation for isotype-specific non-redundancy of TUBB4A
• No defined mechanism linking microtubule accumulation to oligodendrocyte cell death
• Whether the cancer-context signaling functions of TUBB4A are relevant to neurological disease is untested